Table 3.
Compounda | R” | %L-Phe Effluxb |
% Inhibitionc |
IC50 ((μM)d |
---|---|---|---|---|
45 (Gly) |
H (achiral) | 29 | 33 | - |
46 (L-Leu) |
(CH3)2CHCH2- | 120 | 73 | 85 ± 21 |
46-D (D-Leu) |
(CH3)2CHCH2- | 56 | 220 ± 47 | |
47 (L-Ile) |
(S)-CH3CH2(CH3)CH- | 93 | - | 140 ± 27 |
47-D (D-Ile) |
(S)-CH3CH2(CH3)CH- | 78 | 18 | >3,000 |
48 (L-Met) |
CH3S(CH2)2- | 89 | - | 170 ±23 |
48-D (D-Met) |
CH3S(CH2)2 | 110 | 56 | 120 ±33 |
49 (L-Val) |
(CH3)2CH- | 100 | 43 | 68 ±21 |
49 D (D-Val) |
(CH3)2CH- | 41 | 11 | >50,000 |
50 (L-Phe) |
PhCH2- | 100 | 85 | 69 ±29 |
50-D (D-Phe) |
PhCH2- | 96 | 74 | 46 ±23 |
51 (L-Tyr) |
para-HOPhCH2- | 96 | 68 | 68 ± 34 |
51-D (D-Tyr) |
para-HOPhCH2- | 85 | 35 | 380 ± 73 |
52 (L-Trp) |
59 | 79 | 160 ± 87 | |
52-D (D-Trp) |
81 | 29 | 380 ± 130 | |
53 (L-His) |
140 | 92 | 20 ± 9 | |
53-D (D-His) |
78 | 33 | 460 ± 170 | |
54 (L-Arg) |
NH2(NH)CNH(CH2)3- | 28 | 49 | - |
55 (L-Lys) |
NH2(CH2)4- | 33 | −2.1 | - |
56 (L-Asp) |
HO2CCH2- | 27 | 4.2 | - |
57 (L-Glu) |
HO2C(CH2)2- | 27 | −2.4 | - |
Cell assay data was obtained at least in triplicate (wells). Amino acids were purchased from commercial vendors. All compounds above are single enantiomers of L configuration, unless indicated otherwise. Most of these amino acids (except 54–57) were converted and tested as their HCl salts to improve water solubility.
Compounds were tested at 200 μM for their ability to cause efflux (fmol/min) of [3H]-gabapentin from preloaded HEK-hLAT1 cells. Efflux of [3H]-gabapentin was calculated at 3 min after adding test compound. %Efflux was normalized relative to L-Phe (50), which had an efflux rate of 2.7 ± 0.3 fmol/min, from an average of seven experiments.
Compounds were tested at 200 μM for their ability to inhibit uptake of [3H]-gabapentin into HEK-hLAT1 cells. Data is presented as % inhibition relative to background signal in the absence of a test compound.
For IC50 determinations, varying concentrations of each compound were added, from 0.1 to 500 μM. IC50 and standard deviation of each compound were calculated by Graphpad Prism version 5.0. %[3H]-gabapentin uptake at each concentration was normalized relative to % inhibition by BCH80,81 at 2 mM, which was set to 100% inhibition.